Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Dec;5(6):119-23.
Epub 2013 Dec 26.

Current advances in radiotherapy of head and neck malignancies

G Roopashri  1 , Muqeet Baig  2
Affiliations
Review

Current advances in radiotherapy of head and neck malignancies

G Roopashri et al. J Int Oral Health. 2013 Dec.

Abstract

Necessity is the mother of all inventions. This is also true in case of cancer therapy. With increasing incidence of head and neck malignancies, remarkable developments have been made towards cancer development and treatment which continues to be a major challenge. Approximately fifty percent of all cancer patients receive radiotherapy which contributes towards forty percent of curative treatment for cancer. New developments in radiation oncology have helped to improve outlook for patients and find more effective treatment. With the advent of new technologies, radiotherapy seems to be promising in patients with head and neck malignancies these advancements include Altered fractionation, Three-dimensional conformal radiotherapy, Intensity-modulated radiotherapy, Image Guided Radiotherapy, Stereotactic radiation, Charged-particle radiotherapy, and Intraoperative radiotherapy. How to cite this article: Roopashri G, Baig M. Current advances in radiotherapy of head and neck malignancies. J Int Oral Health 2013; 5(6):119-23 .

Keywords: Head and neck malignancy; image guided radiotherapy; intensity-modulated radiotherapy; three -dimensional conformal radiotherapy.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None Declared

References

    1. International Commission on Radiation Units: Prescribing, recording and reporting photon beam therapy. Supplement to ICRU Report 50. Bethseda:International Commission on Radiation Units and Measurement, MD, ICRU. 1999
    1. S Bhide, T Guerrero Urbano, C Clark, V Hansen, E Adams, E Miles, H McNair, A Warrington, K Harrington, C Nutting. Results of intensity modulated radiotherapy (IMRT) in laryngeal and hypopharyngeal cancer: a dose escalation study. Radiother Oncol. 2007;82:74–75.
    1. ST Peeters, WD Heemsbergen, PC Koper, WL van Putten, A Slot, MF Dielwart, JM Bonfrer, L Incrocci, JV Lebesque. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol. 2006;24(13):1990–1996. - PubMed
    1. TG Urbano, CH Clark, VN Hansen, EJ Adams, EA Miles, H Mc Nair, AM Bidmead, J Warrington, DP Dearnaley, C Harmer, KJ Harrington, CM Nutting. Intensity Modulated Radiotherapy (IMRT) in locally advanced thyroid cancer: acute toxicity results of a phase I study. Radiother Oncol. 2007;85(1):58–63. - PubMed
    1. MJ Zelefsky, Z Fuks, M Hunt, HJ Lee, D Lombardi, CC Ling, VE Reuter, ES Venkatraman, SA Leibel. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol. 2001;166(3):876–881. - PubMed

LinkOut - more resources